Fulgent Genetics, Inc.
FLGT
$21.77
$0.3751.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.31% | 1.71% | -1.99% | -3.02% | -5.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.31% | 1.71% | -1.99% | -3.02% | -5.42% |
| Cost of Revenue | 2.70% | -0.44% | -4.60% | -8.77% | -15.26% |
| Gross Profit | 6.80% | 5.30% | 2.64% | 9.09% | 15.44% |
| SG&A Expenses | 4.70% | -1.11% | -4.69% | 9.56% | 0.53% |
| Depreciation & Amortization | 0.89% | 1.25% | 1.53% | 0.43% | -0.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.83% | 1.27% | -1.95% | 1.45% | -5.20% |
| Operating Income | -1.88% | 0.49% | 1.83% | -18.56% | 4.25% |
| Income Before Tax | 63.46% | 70.39% | 70.15% | -203.31% | -142.72% |
| Income Tax Expenses | -210.94% | -226.78% | -805.72% | -752.13% | 140.58% |
| Earnings from Continuing Operations | 69.52% | 75.83% | 74.99% | -164.64% | -240.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -86.10% | -84.95% | -85.00% | 374.88% | 390.47% |
| Net Income | 68.78% | 75.43% | 74.55% | -159.76% | -235.71% |
| EBIT | -1.88% | 0.49% | 1.83% | -18.56% | 4.25% |
| EBITDA | -6.64% | -3.00% | 0.33% | -39.73% | -9.30% |
| EPS Basic | 69.57% | 75.99% | 74.89% | -158.64% | -233.61% |
| Normalized Basic EPS | -16.99% | -4.05% | 6.14% | 14.71% | 47.47% |
| EPS Diluted | 69.58% | 76.00% | 74.90% | -157.14% | -231.94% |
| Normalized Diluted EPS | -16.99% | -4.05% | 6.14% | 14.71% | 47.52% |
| Average Basic Shares Outstanding | 2.33% | 2.20% | 1.51% | 0.90% | 0.42% |
| Average Diluted Shares Outstanding | 2.33% | 2.20% | 1.51% | 0.90% | -0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |